109 related articles for article (PubMed ID: 20079437)
1. Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosis.
Achiron A; Grotto I; Balicer R; Magalashvili D; Feldman A; Gurevich M
Neurobiol Dis; 2010 May; 38(2):201-9. PubMed ID: 20079437
[TBL] [Abstract][Full Text] [Related]
2. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse.
Achiron A; Feldman A; Mandel M; Gurevich M
Ann N Y Acad Sci; 2007 Jun; 1107():155-67. PubMed ID: 17804543
[TBL] [Abstract][Full Text] [Related]
3. Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis.
Satoh J; Nakanishi M; Koike F; Miyake S; Yamamoto T; Kawai M; Kikuchi S; Nomura K; Yokoyama K; Ota K; Kanda T; Fukazawa T; Yamamura T
Neurobiol Dis; 2005 Apr; 18(3):537-50. PubMed ID: 15755681
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.
Bomprezzi R; Ringnér M; Kim S; Bittner ML; Khan J; Chen Y; Elkahloun A; Yu A; Bielekova B; Meltzer PS; Martin R; McFarland HF; Trent JM
Hum Mol Genet; 2003 Sep; 12(17):2191-9. PubMed ID: 12915464
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery?
Brynedal B; Khademi M; Wallström E; Hillert J; Olsson T; Duvefelt K
Neurobiol Dis; 2010 Mar; 37(3):613-21. PubMed ID: 19944761
[TBL] [Abstract][Full Text] [Related]
6. Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects.
Tian Y; Apperson ML; Ander BP; Liu D; Stomova BS; Jickling GC; Enriquez R; Agius MA; Sharp FR
J Neuroimmunol; 2011 Jan; 230(1-2):124-9. PubMed ID: 20920832
[TBL] [Abstract][Full Text] [Related]
7. T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients.
Satoh J; Nakanishi M; Koike F; Onoue H; Aranami T; Yamamoto T; Kawai M; Kikuchi S; Nomura K; Yokoyama K; Ota K; Saito T; Ohta M; Miyake S; Kanda T; Fukazawa T; Yamamura T
J Neuroimmunol; 2006 May; 174(1-2):108-18. PubMed ID: 16564577
[TBL] [Abstract][Full Text] [Related]
8. Regulation of gene expression associated with acute experimental autoimmune encephalomyelitis by Lovastatin.
Paintlia AS; Paintlia MK; Singh AK; Stanislaus R; Gilg AG; Barbosa E; Singh I
J Neurosci Res; 2004 Jul; 77(1):63-81. PubMed ID: 15197739
[TBL] [Abstract][Full Text] [Related]
9. D-Serine exposure resulted in gene expression changes implicated in neurodegenerative disorders and neuronal dysfunction in male Fischer 344 rats.
Davidson ME; Kerepesi LA; Soto A; Chan VT
Arch Toxicol; 2009 Aug; 83(8):747-62. PubMed ID: 19212759
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment.
Lindberg RL; Kappos L
Expert Rev Mol Diagn; 2006 Nov; 6(6):843-55. PubMed ID: 17140371
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis.
Hong J; Zang YC; Hutton G; Rivera VM; Zhang JZ
J Neuroimmunol; 2004 Jul; 152(1-2):126-39. PubMed ID: 15223245
[TBL] [Abstract][Full Text] [Related]
12. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis.
Compston A; Kellar-Wood H; Wood N
Baillieres Clin Neurol; 1994 Aug; 3(2):353-71. PubMed ID: 7952852
[TBL] [Abstract][Full Text] [Related]
14. Gender-based blood transcriptomes and interactomes in multiple sclerosis: involvement of SP1 dependent gene transcription.
Menon R; Di Dario M; Cordiglieri C; Musio S; La Mantia L; Milanese C; Di Stefano AL; Crabbio M; Franciotta D; Bergamaschi R; Pedotti R; Medico E; Farina C
J Autoimmun; 2012 May; 38(2-3):J144-55. PubMed ID: 22119415
[TBL] [Abstract][Full Text] [Related]
15. Gender effects in relapsing-remitting multiple sclerosis: correlation between clinical variables and gene expression molecular pathways.
Achiron A; Gurevich M
J Neurol Sci; 2009 Nov; 286(1-2):47-53. PubMed ID: 19596127
[TBL] [Abstract][Full Text] [Related]
16. Aberrant transcriptional regulatory network in T cells of multiple sclerosis.
Satoh J; Illes Z; Peterfalvi A; Tabunoki H; Rozsa C; Yamamura T
Neurosci Lett; 2007 Jul; 422(1):30-3. PubMed ID: 17629622
[TBL] [Abstract][Full Text] [Related]
17. Exploiting genotypic differences to identify genes important for EAE development.
Jelinsky SA; Miyashiro JS; Saraf KA; Tunkey C; Reddy P; Newcombe J; Oestreicher JL; Brown E; Trepicchio WL; Leonard JP; Marusic S
J Neurol Sci; 2005 Dec; 239(1):81-93. PubMed ID: 16214174
[TBL] [Abstract][Full Text] [Related]
18. Characterization of multiple sclerosis traits: nuclear receptors (NR) impaired apoptosis pathway and the role of 1-α 25-dihydroxyvitamin D3.
Achiron A; Feldman A; Gurevich M
J Neurol Sci; 2011 Dec; 311(1-2):9-14. PubMed ID: 21752397
[TBL] [Abstract][Full Text] [Related]
19. Association of the PPARgamma gene polymorphism Pro12Ala with delayed onset of multiple sclerosis.
Klotz L; Schmidt S; Heun R; Klockgether T; Kölsch H
Neurosci Lett; 2009 Jan; 449(1):81-3. PubMed ID: 18977277
[TBL] [Abstract][Full Text] [Related]
20. Blood T-cell receptor beta chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution.
Laplaud DA; Ruiz C; Wiertlewski S; Brouard S; Berthelot L; Guillet M; Melchior B; Degauque N; Edan G; Brachet P; Damier P; Soulillou JP
Brain; 2004 May; 127(Pt 5):981-95. PubMed ID: 14985265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
